Target-dosing Anemia Treatments for Patients with Diabetes and Chronic Kidney Disease May Carry Risks

Researchers find that individuals with a poor hemoglobin response to ESAs have a higher risk of death and cardiovascular events.
Source: BWH News - Category: Hospital Management Source Type: news